Search for: "Mylan Laboratories Ltd."
Results 21 - 40
of 116
Sorted by Relevance
|
Sort by Date
18 Dec 2009, 9:59 am
Mylan Pharmaceuticals Inc., Mylan, Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
1 Dec 2009, 9:45 am
Mylan Inc., Matrix Laboratories Limited and Matrix Laboratories, Inc. [read post]
28 Aug 2009, 8:11 am
Mylan Pharmaceuticals Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
11 May 2019, 9:15 am
Neptune Generics, LLC, Fresenius Kabi USA, LLC, and Mylan Laboratories Ltd. [read post]
10 Nov 2020, 2:01 am
” The Venue Dispute At Issue As noted in the Federal Circuit decision, defendant Mylan Pharmaceuticals Inc. is a West Virginia corporation with a principal place of business in Morgantown, West Virginia; defendant Mylan Inc. is a Pennsylvania corporation with a principal place of business in Canonsburg, Pennsylvania, and defendant Mylan Laboratories Ltd. [read post]
17 Feb 2010, 8:00 am
Mylan Pharmaceuticals Inc. [read post]
31 Jan 2013, 7:30 am
Related posts:Patent Litigation Settlement RoundupOn November 8, 2012, Mylan Inc. [read post]
1 Mar 2013, 6:28 am
Related posts:Patent Litigation Settlement RoundupOn November 8, 2012, Mylan Inc. [read post]
6 Nov 2020, 7:16 am
Cir. 1999) In any event, MPI wins this round — with a holding that venue is improper against MPI in New Jersey. = = = = Foreign Defendant: Mylan Laboratories Ltd. [read post]
26 Jun 2007, 10:48 pm
The pharma companies named by the Attorney General are: • Mylan Laboratories Inc. of Pennsylvania (with national subsidiaries Mylan Pharmaceuticals Inc. and UDL Laboratories Inc.) [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd… [read post]
9 Apr 2010, 8:30 am
These companies include Mylan Pharmaceuticals Inc., Roxane Laboratories Inc., and Torrent Pharmaceuticals Ltd. [read post]
27 Jun 2018, 4:19 pm
Int’l Ltd., 887 F.3d 1117 (Fed. [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
25 Jul 2008, 2:11 am
Mylan Laboratories, Inc., 520 F.3d 1358, 1364 (Fed. [read post]
15 Jun 2011, 4:56 am
Mylan Inc. et al. [read post]
27 Jul 2011, 4:06 pm
Caraco :Defendants-Appellees Caraco Pharmaceutical Labora- tories, Ltd. and Sun Pharmaceutical Industries, Ltd. [read post]
24 Mar 2010, 4:45 am
Lupin Ltd. et al. [read post]
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition… [read post]
4 Aug 2010, 12:21 am
Roxane Laboratories Inc. [read post]
